Development of a DNA Vaccine against Cytotoxic T-lymphocyte Associated Antigen-4 (CTLA-4)

Development of a DNA Vaccine against Cytotoxic T-lymphocyte Associated Antigen-4 (CTLA-4)

碩士 === 國立陽明大學 === 生物醫學影像暨放射科學系 === 102 === Significant progress has been made in the field of cancer immunotherapy. American Association for the Advancement of Science (AAAS) had selected cancer immunotherapy as the “breakthrough of the year 2013”. Immunotherapy exerts its function of anticancer eff...

Full description

Bibliographic Details
Main Authors:	Cheng-Liang Tsai, 蔡政良
Other Authors:	Yi-Jang Lee
Format:	Others
Language:	zh-TW
Published:	2014
Online Access:	http://ndltd.ncl.edu.tw/handle/96693177377935770838

Similar Items

Progress in Research on Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) and Bladder Cancer
by: Wei-Ming Fang, et al.
Published: (2019-01-01)

Cytotoxic T-lymphocyte Associated Antigen-4 (CTLA-4) Polymorphism, Cancer, and Autoimmune Diseases
by: Maryam Tanhapour, et al.
Published: (2017-10-01)

Association of Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) and Thyroglobulin (TG) Genetic Variants with Autoimmune Hypothyroidism.
by: Hinal Patel, et al.
Published: (2016-01-01)

Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis
by: Hyosun Cho, et al.
Published: (2017-07-01)

Soluble cytotoxic T-lymphocyte–associated antigen 4 (sCTLA-4) as a potential biomarker for diagnosis and evaluation of the prognosis in Glioma
by: Jiajia Liu, et al.
Published: (2021-05-01)

Single Nucleotide Polymorphisms of Cytotoxic T-lymphocyte Antigen 4 (CTLA-4) and Susceptibility to Chronic Viral Hepatitis B and C Infections
by: Moisés Enciso-Vargas, et al.
Published: (2018-03-01)

Construction of a fusion plasmid containing the PSCA gene and cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and its anti-tumor effect in an animal model of prostate cancer
by: T.J. Mai, et al.

Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study.
by: Wei-Hsin Ting, et al.
Published: (2016-01-01)

Effect of Cytotoxic T-Lymphocyte Antigen-4 on the Efficacy of the Fatty Acid-Binding Protein Vaccine Against Schistosoma japonicum
by: Chun-lian Tang, et al.
Published: (2019-05-01)

Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas.
by: Ari Kassardjian, et al.
Published: (2018-01-01)

Cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA-4-Ig) suppresses Staphylococcus aureus-induced CD80, CD86, and pro-inflammatory cytokine expression in human B cells
by: Po-Chun Liu, et al.
Published: (2020-03-01)

Antitumor immunity of DNA vaccine based on CTLA-4 fused with HER2 against colon carcinoma
by: Shumin Huang, et al.
Published: (2018-04-01)

Lack of association between cytotoxic T-lymphocyte antigen 4 (CTLA-4) -1722T/C (rs733618) polymorphism and cancer risk: from a case-control study to a meta-analysis.
by: Weifeng Tang, et al.
Published: (2014-01-01)

Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma
by: Tosti G, et al.
Published: (2013-10-01)

Fusion with extracellular domain of cytotoxic T-lymphocyte-associated-antigen 4 leads to enhancement of immunogenicity of Hantaan virus DNA vaccines in C57BL/6 mice
by: Wang Shiwen, et al.
Published: (2011-09-01)

Role of CTLA4 in the proliferation and survival of chronic lymphocytic leukemia.
by: Amit K Mittal, et al.
Published: (2013-01-01)

Cytotoxic T-lymphocyte associated antigen 4 polymorphisms and asthma risk: a meta-analysis.
by: Wei Nie, et al.
Published: (2012-01-01)

Cytotoxic T Lymphocytes and Vaccine Development
by: Zhengguo Xiao, et al.
Published: (2010-01-01)

The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab, in the treatment of melanoma
by: Verschraegen C
Published: (2012-01-01)

The Role of Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) Gene, Thyroid Stimulating Hormone Receptor (TSHR) Gene and Regulatory T-cells as Risk Factors for Relapse in Patients with Graves Disease
by: Fatimah Eliana, et al.
Published: (2017-11-01)

Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine
by: Afshin Derakhshani, et al.
Published: (2021-05-01)

Cytotoxic T Lymphocytes and Vaccine Development 2013
by: Zhengguo Xiao, et al.
Published: (2013-01-01)

Cytotoxic T Lymphocytes and Vaccine Development 2011
by: Zhengguo Xiao, et al.
Published: (2011-01-01)

A CTLA-4 Antagonizing DNA Aptamer with Antitumor Effect
by: Bo-Tsang Huang, et al.
Published: (2017-09-01)

Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies
by: Min Fang, et al.
Published: (2018-05-01)

Enhanced Antitumor Immunity by Fusion of CTLA-4 to A Self Tumor Antigen
by: Tzu-Hsuan Huang, et al.
Published: (2000)

Soluble cytotoxic T-lymphocyte antigen 4: a favorable predictor in malignant tumors after therapy
by: Liu Q, et al.
Published: (2017-04-01)

The potential effects of Cytotoxic T lymphocyte antigen 4 -Ig on human B cell response
by: Chih-Tai Ssu, et al.
Published: (2017)

Increasing a Robust Antigen-Specific Cytotoxic T Lymphocyte Response by FMDV DNA Vaccination with IL-9 Expressing Construct
by: Qiang Zou, et al.
Published: (2010-01-01)

An Activating Janus Kinase-3 Mutation Is Associated with Cytotoxic T Lymphocyte Antigen-4-Dependent Immune Dysregulation Syndrome
by: Heiko Sic, et al.
Published: (2017-12-01)

Recognition of antigen and superantigen by cytotoxic T lymphocytes
by: Bowness, Paul
Published: (1993)

Presentation of peptide antigens to cytotoxic T lymphocytes
by: Elvin, John G.
Published: (1992)

Cytotoxic effects of antigen-transformed lymphocytes
by: Butterworth, A. E.
Published: (1973)

Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients
by: L. Karabon, et al.
Published: (2020-01-01)

Fusion of CTLA-4 with HPV16 E7 and E6 enhanced the potency of therapeutic HPV DNA vaccine.
by: Lili Gan, et al.
Published: (2014-01-01)

Cytotoxic T Lymphocyte-Associated Antigen 4 Gene Polymorphisms and Autoimmune Thyroid Diseases: An Updated Systematic Review and Cumulative Meta-Analysis
by: Hai-Feng Hou, et al.
Published: (2015-01-01)

Cytotoxic T Lymphocyte Antigen-4 Gene Variants in Type 2 Diabetic Patients with or without Neuropathy
by: Javad Kiani, et al.
Published: (2016-06-01)

Genetic Polymorphisms of Cytotoxic T-Lymphocyte Antigen 4 in Primary Biliary Cholangitis: A Meta-Analysis
by: Xing-Chen Yang, et al.
Published: (2017-01-01)

Association of Cytotoxic T Lymphocyte Antigen-4 Gene Polymorphisms with Psoriasis Vulgaris: A Case-Control Study in Turkish Population
by: Hatice Gül Dursun, et al.
Published: (2018-01-01)

Association between the <it>Cytotoxic T-Lymphocyte Antigen 4 </it>+49G > A polymorphism and cancer risk: a meta-analysis
by: Lu Jiachun, et al.
Published: (2010-10-01)